192 filings
8-K
TVTX
Travere Therapeutics Inc
13 May 24
Departure of Directors or Certain Officers
4:05pm
8-K
TVTX
Travere Therapeutics Inc
6 May 24
Travere Therapeutics Reports First Quarter 2024 Financial Results
4:05pm
8-K
TVTX
Travere Therapeutics Inc
24 Apr 24
Other Events
4:05pm
8-K
TVTX
Travere Therapeutics Inc
23 Feb 24
Other Events
4:05pm
8-K
TVTX
Travere Therapeutics Inc
15 Feb 24
Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
8-K
ew77clwp9au ba
8 Jan 24
Travere Therapeutics Provides Corporate Update and 2024 Outlook
7:07am
8-K
zezm738czycdgbc 4g
4 Dec 23
Cost Associated with Exit or Disposal Activities
4:10pm
8-K
820 9nsov
7 Nov 23
Travere Therapeutics Reports Third Quarter 2023 Financial Results
4:04pm
8-K
mns km25mc8k8n1y
21 Sep 23
Other Events
7:35am
8-K/A
ah3f35wa
7 Sep 23
Financial Statements and Exhibits
5:00pm
8-K
tnmhe7wc
5 Sep 23
Completion of Acquisition or Disposition of Assets
8:35am
8-K
lsw n0fnju81
3 Aug 23
Travere Therapeutics Reports Second Quarter 2023 Financial Results
4:06pm
8-K
5bsyi pumgsfkdnm6cc
17 Jul 23
Entry into a Material Definitive Agreement
8:07am
8-K
cjk u3lk9a9ip
31 May 23
Other Events
4:57pm
8-K
t40tec54wjrskxwh5o
22 May 23
Departure of Directors or Certain Officers
4:30pm
8-K
szgw7 vijsjlq
4 May 23
Travere Therapeutics Reports First Quarter 2023 Financial Results
4:05pm
8-K
fwnvwnfkpdwpp 3xylkd
1 May 23
Other Events
4:07pm
8-K
iif49q xzae12
12 Apr 23
Changes in Registrant's Certifying Accountant
4:30pm
8-K
qt6mqlta6ahtaydt5o
1 Mar 23
Travere Therapeutics Announces Proposed Public Offering of Common Stock
5:17pm
8-K
kr7 60wg6
23 Feb 23
Travere Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
4:05pm